P-015: A responder analysis of MPC-7869 (tarenflurbil), a selective Aβ42-lowering agent, in mild Alzheimer’s disease (AD): Analysis from a phase 2 study of up to 24 months of treatment

✍ Scribed by Kenton H. Zavitz; Suzanne Hendrix; Mark Laughlin; Edward Swabb

• Book ID: 118463325
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 61 KB
• Volume: 3
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2007.04.231